Literature DB >> 17488725

Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities. Control of TIA-1 isoform ratio by TIA-1-related protein.

José M Izquierdo1, Juan Valcárcel.   

Abstract

TIA-1 (T-cell Intracellular Antigen 1) and TIAR (TIA-1-related protein) are RNA-binding proteins involved in the regulation of alternative pre-mRNA splicing and other aspects of RNA metabolism. Various isoforms of these proteins exist in mammals. For example, TIA-1 presents two major isoforms (TIA-1a and TIA-1b) generated by alternative splicing of exon 5 that differ by eleven amino acids exclusive of the TIA-1a isoform. Here we show that the relative expression of TIA-1 and TIAR isoforms varies in different human tissues and cell lines, suggesting distinct functional properties and regulated isoform expression. We report that whereas TIA-1 isoforms show similar subcellular distribution and RNA binding, TIA-1b displays enhanced splicing stimulatory activity compared with TIA-1a, both in vitro and in vivo. Interestingly, TIAR depletion from HeLa and mouse embryonic fibroblasts results in an increased ratio of TIA-1b/a expression, suggesting that TIAR regulates the relative expression of TIA-1 isoforms. Taken together, the results reveal distinct functional properties of TIA-1 isoforms and the existence of a regulatory network that controls isoform expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488725     DOI: 10.1074/jbc.M700688200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy.

Authors:  Natalia N Singh; Joonbae Seo; Eric W Ottesen; Maria Shishimorova; Dhruva Bhattacharya; Ravindra N Singh
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

2.  Fas splicing regulation during early apoptosis is linked to caspase-mediated cleavage of U2AF65.

Authors:  José M Izquierdo
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

Review 3.  T-cell intracellular antigens in health and disease.

Authors:  Carmen Sánchez-Jiménez; José M Izquierdo
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

4.  Regulation of alternative splicing by the core spliceosomal machinery.

Authors:  Arneet L Saltzman; Qun Pan; Benjamin J Blencowe
Journal:  Genes Dev       Date:  2011-02-15       Impact factor: 11.361

5.  Structure of the central RNA recognition motif of human TIA-1 at 1.95A resolution.

Authors:  Amit O Kumar; Matthew C Swenson; Matthew M Benning; Clara L Kielkopf
Journal:  Biochem Biophys Res Commun       Date:  2008-01-15       Impact factor: 3.575

6.  Induction of stress granule-like structures in vesicular stomatitis virus-infected cells.

Authors:  Phat X Dinh; Lalit K Beura; Phani B Das; Debasis Panda; Anshuman Das; Asit K Pattnaik
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  The involvement of mRNA processing factors TIA-1, TIAR, and PABP-1 during mammalian hibernation.

Authors:  Shannon N Tessier; Timothy E Audas; Cheng-Wei Wu; Stephen Lee; Kenneth B Storey
Journal:  Cell Stress Chaperones       Date:  2014-03-04       Impact factor: 3.667

8.  A Heterologous Cell Model for Studying the Role of T-Cell Intracellular Antigen 1 in Welander Distal Myopathy.

Authors:  Isabel Carrascoso; Carmen Sánchez-Jiménez; Elena Silion; José Alcalde; José M Izquierdo
Journal:  Mol Cell Biol       Date:  2018-12-11       Impact factor: 4.272

9.  Heterogeneous nuclear ribonucleoprotein K supports vesicular stomatitis virus replication by regulating cell survival and cellular gene expression.

Authors:  Phat X Dinh; Anshuman Das; Rodrigo Franco; Asit K Pattnaik
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

10.  Depletion of T-cell intracellular antigen proteins promotes cell proliferation.

Authors:  Raquel Reyes; José Alcalde; José M Izquierdo
Journal:  Genome Biol       Date:  2009-08-26       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.